Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Veratridine: A Precision Voltage-Gated Sodium Channel Opener

    2026-01-20

    Veratridine: A Precision Voltage-Gated Sodium Channel Opener for Advanced Research

    Principle Overview: Harnessing the Power of a Steroidal Alkaloid Neurotoxin

    Veratridine (CAS: 71-62-5), a steroidal alkaloid neurotoxin derived from Veratrum species, is a potent and selective voltage-gated sodium channel opener. By binding to site 2 on the sodium channel α-subunit, it prevents inactivation and induces persistent membrane depolarization in excitable cells. This precise mechanism renders Veratridine a cornerstone reagent for sodium channel dynamics research, excitotoxicity studies, seizure mechanism research, and as a functional probe in screening assays for sodium channel blockers.

    APExBIO’s Veratridine (SKU: B7219) offers a validated, high-purity preparation suitable for both in vitro and in vivo applications. Its unique properties also make it a strategic tool for emerging fields such as UBXN2A protein enhancer studies, colon cancer research, and cancer chemosensitivity modulation via the caspase signaling pathway and mortalin-2 dependent cancer cell death.

    Step-by-Step Experimental Workflow: Optimizing Veratridine-Based Assays

    1. Solution Preparation and Handling

    • Solubility: Dissolve Veratridine in DMSO at concentrations >33.69 mg/ml (>10 mM). Prepare fresh aliquots to avoid degradation; long-term storage of solutions is not recommended.
    • Storage: Store Veratridine powder at -20°C in a desiccated environment for maximal stability.
    • Working Concentrations: For neuronal excitability and sodium current assays, typical final concentrations range from 1 to 50 μM, titrated based on cell type and sensitivity.

    2. Workflow for Sodium Channel Dynamics Research

    1. Plate preparation: Seed primary neurons, stem cell-derived cardiomyocytes, or cancer cells in multiwell plates at desired densities.
    2. Treatment: Add Veratridine to the culture medium at the optimized working concentration. For acute assays, a 5–30 minute exposure is standard; for chronic effects, treat for up to 24 hours, monitoring for cytotoxicity.
    3. Readouts: Measure sodium currents (patch-clamp), membrane potential (voltage-sensitive dyes), or downstream markers such as intracellular Ca2+ (fluorescence imaging).
    4. Endpoint assays: For cancer or excitotoxicity studies, assess cell viability (MTT/XTT), apoptosis (caspase activity), or UBXN2A expression (Western blot/qPCR).

    3. Enhanced Protocols for Advanced Applications

    • UBXN2A and Mortalin-2 Pathways: For studies of cancer chemosensitivity modulation, treat cells with Veratridine and measure UBXN2A and mortalin-2 protein levels. Recent in vitro work demonstrates a dose-dependent increase in UBXN2A, linked with increased cancer cell apoptosis via the caspase pathway.
    • In Vivo Studies: In murine models, intraperitoneal injection of Veratridine at 0.125 mg/kg daily for 28 days robustly induced UBXN2A expression and promoted colon cancer cell death, as quantified by histological and molecular analyses.
    • Cardiac Modeling: Incorporate Veratridine in functional assays with human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) to probe chamber-specific electrophysiological properties. As described in the 2025 study by Saito et al., Veratridine can be used to verify sodium channel functionality in both right ventricular (RV)-like and left ventricular (LV)-like hPSC-CMs, supporting precise disease modeling workflows.

    Advanced Applications & Comparative Advantages

    1. Neuroscience Research: Excitotoxicity and Seizure Models

    Veratridine is instrumental in dissecting the molecular underpinnings of excitotoxicity and seizure mechanisms. Its capacity to induce sustained depolarization makes it a gold standard tool for:

    • Modeling epileptiform activity in neural cultures and brain slices
    • Screening anti-epileptic compounds targeting sodium channel inactivation
    • Elucidating sodium channel subtype contributions to neuronal excitability

    Compared to other sodium channel openers, Veratridine’s affinity for site 2 and its stability in DMSO provide enhanced reproducibility and specificity.

    2. High-Throughput Screening Assays for Sodium Channel Blockers

    As a robust voltage-gated sodium channel opener, Veratridine enables the development of sensitive, high-throughput assays for identifying and ranking sodium channel blockers. Assays leveraging Veratridine-induced depolarization exhibit high Z’ factors (≥0.7), supporting reliable screening and drug discovery campaigns. The workflow is further detailed in the article "A Precision Tool for Sodium Channel Dynamics", which complements these protocols with integration tips for chamber-specific cellular models.

    3. Oncology: Modulating Cancer Chemosensitivity

    Recent translational insights underscore Veratridine’s value as a UBXN2A protein enhancer and modulator of cancer cell fate. The compound selectively increases UBXN2A expression in a dose-responsive manner, promoting cancer cell death through mortalin-2 dependent and caspase signaling pathways. In colon cancer models, Veratridine treatment led to a >50% reduction in tumor cell viability and significant upregulation of pro-apoptotic markers, as validated by multiple independent studies.

    For further context, the article "Expanding the Frontiers of Sodium Channel Research" extends this discussion by exploring Veratridine’s unique intersection between sodium channel modulation and cancer therapeutics, providing actionable strategies for integrating sodium channel dynamics research with oncology pipelines.

    4. Cardiac Disease Modeling and Chamber-Specific Differentiation

    Cardiac research has benefited from Veratridine’s precise modulation of sodium currents, particularly in the context of chamber-specific cardiomyocyte differentiation. The Saito et al. (2025) study demonstrates the use of human pluripotent stem cell-derived right ventricular cardiomyocytes (hPSC-RV-CMs) to uncover distinct electrophysiological features, where Veratridine challenges reveal differential sodium channel functionality and disease susceptibility. This extends prior foundational work (see "Mechanistic Leverage and Strategic Guidance") by providing a practical template for integrating Veratridine in advanced cardiac modeling workflows.

    Troubleshooting & Optimization Tips

    • Compound Stability: Always prepare Veratridine stock solutions fresh before each experiment. Avoid repeated freeze-thaw cycles; aliquot upon initial dissolution.
    • DMSO Concentration: Maintain final DMSO content ≤0.1% in cell-based assays to prevent solvent-induced cytotoxicity.
    • Concentration Titration: Begin with pilot dose-response studies to establish the minimal effective concentration for your specific cell model. Overshooting can induce non-specific toxicity, confounding interpretation.
    • Assay Time Course: For acute sodium current activation, restrict exposure to ≤30 minutes. For chronic endpoint assays (e.g., apoptosis or protein expression), monitor cell health frequently and include vehicle controls.
    • Batch Consistency: Use a single lot of APExBIO Veratridine for multi-assay projects to ensure performance reproducibility. Document lot numbers and storage conditions in your protocols.
    • Signal Readout Optimization: When using voltage-sensitive dyes or calcium indicators, validate that Veratridine-induced responses are within the dynamic range of your detection system. High depolarization may saturate some probes.

    For a deeper dive into troubleshooting sodium channel assays and optimizing chemosensitivity protocols, the review "A Steroidal Alkaloid Tool for Sodium Channel Research" complements these practical strategies with comparative data and decision trees.

    Future Outlook: Expanding the Translational Frontier with Veratridine

    Veratridine’s unique mechanism—a selective, persistent activation of voltage-gated sodium channels—continues to position it as a platform tool for translational research. Next-generation applications include:

    • Personalized Disease Modeling: Integration with patient-derived stem cell systems for tailored drug discovery and mechanistic studies of arrhythmias, epilepsy, and right/left ventricular dysfunction.
    • Oncology Precision Medicine: Leveraging the UBXN2A and mortalin-2 axis for stratified cancer therapy protocols, supported by robust in vivo efficacy data.
    • Screening Platform Enhancement: Fusing Veratridine-based assays with automated electrophysiology and high-content imaging to accelerate sodium channel blocker discovery and mechanistic profiling.

    As highlighted in recent reference and review articles, including the comprehensive overview "Mechanistic Mastery and Strategic Leverage", Veratridine’s translational utility is poised to deepen with ongoing innovations in cell model engineering and molecular profiling.

    For researchers seeking a reliable, high-purity voltage-gated sodium channel opener, Veratridine from APExBIO stands as the validated, performance-driven choice for unlocking new frontiers in neuroscience, oncology, and cardiac disease modeling.